In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

Lucknow: Patients admitted to the King George's Medical University's (KGMU) trauma centre will receive free diagnostic tests ...

Accreditation reflects the company’s adherence to the highest standards of laboratory quality, stewardship, and ...

Elecsys® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology Now available nationwide in primary ...

Biologically optimised plasma p-tau217 cutoffs improve amyloid beta detection accuracy and cost efficiency. Learn more about ...

FDA clears 1st blood test for Alzheimer’s to help primary care clinicians assess cognitive decline without brain scans or lumbar punctures.

In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...

The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

In medieval Denmark, death could double as a display of status. The closer your grave lay to a church wall or inside a ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

Jenna Watkins was left on a remote mountain road by her boyfriend, who claimed she died in a crash.